Sign In
Last checked at 
25 Oct 2023 07:00
Abingdon Health plc
("Abingdon Health" or the "Company")
Director Dealing
York, U.K. 25 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests announces that on the 24th October 2023, Dr Chris Hand, Non-Executive Chairman purchased ordinary shares of 0.025 pence each in the Company ("Ordinary Shares").
Further details are as follows:
Director | No. Ordinary Shares Purchased | Aggregate Purchase Price (Pence per Ordinary Share) | Enlarged Holding (No. Ordinary Shares) | Enlarged Holding* (Per cent. of Total Voting Rights) |
Dr Chris Hand | 150,000 | 10.167 | 13,178,467 | 10.83% |
*Excluding options over Ordinary Shares
The Notification of Dealing Form required in accordance with UK MAR is set out below.
Enquiries:
Abingdon Health plc | www.abingdonhealth.com/investors/ | |
Chris Yates, Chief Executive Officer | Via Walbrook PR | |
Chris Hand, Non-Executive Chairman |
| |
|
| |
|
| |
Singer Capital Markets (Sole Broker and Nominated Adviser) | Tel: +44 (0)20 7496 3000 | |
Peter Steel, Alex Bond, Jalini Kalaravy |
| |
| ||
| ||
Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com | |
Paul McManus, Phillip Marriage, Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082 +44 (0)7407 804 654 | |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Dr Chris Hand
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-Executive Chairman | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Abingdon Health plc | |||
b)
| LEI
| 213800XFI4WV3FBILO20
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 0.025 pence each
| |||
Identification code | GB00BLF79J41 | ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares
| |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
10 pence per share 10.5 pence per share | 100,000 50,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 150,000 | ||||
- Price | 10.167 pence per share | ||||
e)
| Date of the transaction
| 24th October 2023 | |||
f) | Place of the transaction | London Stock Exchange, AIM | |||
About Abingdon Health plc
Abingdon Health is a leading lateral flow contract research ("CRO") and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."
The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes.
Abingdon Health's Abingdon Simply Test? range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test? ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York, England.
For more information visit: www.abingdonhealth.com
Follow the stocks
